World Briefs

AP Wire Published:

TORONTO Canadian regulators ordered a drug for attention deficit hyperactivity disorder off the market because of reports that it has been linked to 20 sudden deaths and a dozen strokes, including some among children. The U.S. Food and Drug Administrati